I’ve done a bit of research into the newcomers, but what is available on the internet is not enough. Does anyone know of the new team? Are they ethical? Do they practice sound business practice? By forcing the retraction of the placement it seems that they are comfortable with fairly aggressive business practices.
Im for the “old” team. I sympathise with those that unfortunately lost a lot of money, but maintain that management ran a well structured, well planned clinical trial and acted ethically throughout (including the responsible winding down of the programs post-trial).
FTT Price at posting:
0.3¢ Sentiment: Buy Disclosure: Not Held
